Investors
Navigation
  • Home
  • Team
  • Companies
  • News & Ideas
  • Careers
  • Investor Portal
Address
BOLD Capital Partners
BOLD Longevity Growth

225 Santa Monica Blvd, Suite 900
Santa Monica, CA 90401

100 Cambridge Street
Boston, MA 02114
Google Maps
Contacts
Email us
Socials
LinkedIn Twitter
Recent Investments
ProRata.ai
ProRata.ai ProRata.ai
Matrisome Bio
Matrisome Bio Matrisome Bio
Aqtual
Aqtual Aqtual
Discure
Discure Discure
Feno Labs
Feno Labs Feno Labs

Discure

 - 
Discure -  Discure - 
Discure Discure
Discure is designed to treat and reverse degenerative disc disease (DDD), healing the discs, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, Discure is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery.
Yuval Mandelbaum
Yuval Mandelbaum CEO
Follow
  • LinkedIn
  • Company News
    View All News
    Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease
    Healthcare

    Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease

    03.04.25

    Read more

    Discure Technologies Announces $16 Million in Financing Led by BOLD Capital Partners, Supernova Invest and Sanara Capital
    Healthcare

    Discure Technologies Announces $16 Million in Financing Led by BOLD Capital Partners, Supernova Invest and Sanara Capital

    09.10.24

    Read more

    View All News & Ideas
    Curebase
    Curebase
    Next